Deepnoid, a medical AI company, has announced a strategic partnership with K-BioHealthcare, a local healthcare ICT solution firm, to develop personalized digital healthcare solutions aimed at enhancing individual health management.
Under the accord, the two companies plan to create advanced healthcare solutions that empower users to manage their health information proactively.
Central to the partnership is the integration of Personal Data Storage (PDS) technology, ensuring that users can securely store and utilize their health data. This will enable individuals to self-monitor their health status and improve access to preventative healthcare and medical services.
"K-BioHealthcare possesses innovative ideas for data utilization, and we have the technology to leverage data with AI,” Deepnoid CEO Choi Woo-shik said. “We aim to contribute to improving many people's health and quality of life through AI-based innovative medical solutions."
K-BioHealthcare CEO Lee Sang-ho also said, "This agreement combines our expertise to provide more effective and safer personal health management services.”
K-BioHealthcare is committed to enhancing health promotion through the development of innovative healthcare solutions, Lee added.
Related articles
- Deepnoid and Indonesia hospital collaborate on medical AI clinical study
- Medical AI companies begin to supply homegrown solutions
- Korean medical device makers target Middle East market with high potential
- [Contribution] The roles of doctors and AI in the age of medical AI
- Deepnoid and GeneCast to codevelop early cancer-detection tech
- ‘Deepnoid’s M4CXR outperforms ChatGPT in chest X-ray’
- [Interview] Deepnoid bets on Japan as AI testing ground before a push into US
- Can generative AI transform medical imaging and diagnosis?
